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Abstract
Genetic analysis of selected genome regions of hepatitis A virus (HAV) suggested that distinct genotypes of HAV could be found in
different geographical regions. At least seven HAV genotypes have been identified all over the world, including four human genotypes (I,
II, III, and VII) and three simian strains (IV, V, and VI). Phylogenetic analysis using full-length VP1 sequences revealed that human strain
9F94 has a close genetic relation with strain SLF-88 (sub-genotype VII). Nevertheless, the same analysis using full-length VP2 or VP3
sequences revealed that strain 9F94 has a close genetic relation with strain MBB (sub-genotype IB). To test the possibility of genetic
recombination, phylogenetic studies were carried out, revealing that a crossing over had taken place in the VP1 capsid protein. These
findings indicate that capsid-recombination can play a significant role in shaping the genetic diversity of HAV and, as such, can have
important implications for its evolution, biology, and control.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
Human hepatitis A virus (HAV) is a hepatotropic mem-
ber of the family Picornaviridae (Matthews, 1982; Melnick,
1982). Despite its overall physical and epidemiologic sim-
ilarity to enteroviruses, the structural composition of HAV,
its tissue tropism, and genetic distance from other members
of the family indicate that HAV is unique within this family
(Cuthbert, 2001; Hollinger and Ticehurst, 1996). Early
comparative studies of the nucleotide sequences of different
HAV strains suggested that isolates of diverse origin were
closely related (Robertson et al., 1991). More recently nu-
cleotide sequencing of variable genome regions, encoding
the VP1 amino-terminus and the putative VP1/2A junction
of wild-type HAV strains from different regions of the
world, has demonstrated substantial sequence heterogeneity
(Costa-Mattioli et al., 2001a,b, 2002; Jansen et al., 1990;
Robertson et al., 1991, 1992). On the basis of the genetic
variability observed within the putative VP1/2A junction,
seven HAV genotypes have been identified worldwide
(Robertson et al., 1992). However, an extensive molecular
epidemiology study of HAV strains recovered from differ-
ent countries revealed that HAV strains clustered in five
distinct and well-supported genetic lineages (Costa-Mattioli
et al., 2002).
RNA viruses exploit all known mechanisms of genetic
variation to ensure their survival (Domingo and Holland,
1997). Their high rate of mutation and replication allow
them to move through sequence space at a pace that often
makes their DNA-based host’s evolution look glacial by
comparison (Worobey and Holmes, 1999). Over the last two
decades it has become increasingly clear that many RNA
viruses add the capacity to exchange genetic material with
one another. So, in addition to producing large amounts of
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the raw material of evolution (mutations), these viruses also
possess mechanisms that, in principle, allow them both to
purge their genomes of accumulated deleterious changes
(Muller, 1964) and to create or spread beneficial combina-
tions of mutations in an efficient manner.
Genetic exchange among HAV strains has been observed
in cell culture (Beard et al., 2001; Lemon et al., 1991).
Recently, genetic recombination using an HAV subgenomic
replicon constructed by replacing the P1 domain encoding
region protein with the firefly luciferase sequence was
shown (Gauss-Muller and Kusov, 2002). Here we report
evidence of recombination in natural populations of HAV.
Recombination involving two different strains can be de-
tected when phylogenetic analysis reveals different evolu-
tionary histories for different genome regions as, for exam-
ple, in HIV (Robertson et al., 1995). In the present study, we
have obtained sequence data corresponding to full-length
coding sequences of VP1, VP2, and VP3 of HAV strain
9F94, recently isolated from a patient in Morocco, and
compared them with corresponding sequences from HAV
strains of all available genotypes. This work revealed a
different evolutionary history for 9F94 VP1 than for VP2,
VP3, and VP1/2A protein regions and a recombination
event inside the VP1 protein. As consequence, genetic re-
combination provides an additional mechanism of evolution
for HAV that was not previously appreciated and presents
an added complication to the genetic classification of HAV.
Results
Phylogenetic analysis of HAV strains
HAV strains can be segregated into seven genotypes
based on comparison of a short, selected, 168-long nucleic
acid sequence of the HAV genome. Based on comparison of
this short sequence, a recently recovered HAV isolate called
9F94 was classified as genotype II (Costa-Mattioli et al.,
2002). We were interested in testing this classification by
further sequence analysis, and therefore, complete se-
quences spanning the entire capsid coding region were ob-
tained and used throughout all the recombination tests.
These sequences were aligned with sequences from 10
isolates of HAV strains isolated elsewhere for whom com-
plete VP1, VP2, and VP3 sequences were available (for
names, types, and accession numbers, see Table 1). Once
aligned, using the Kimura two-parameters model and the
neighbor-joining method, phylogenetic trees were obtained
for VP1, VP2, and VP3 genes (Figs. 1A, B, and C, respec-
tively). As can be seen in these figures, the phylogenetic
analysis for the VP1 gene revealed that 9F94 (which was
presumptively classified as genotype II based on the pre-
liminary 168-nt VP/2A sequence; Costa-Mattioli et al.,
2002) has a close genetic relation with strain SLF-88 (ge-
notype VII, see Fig. 1A). However, the phylogenetic anal-
ysis done using full-length VP2 or VP3 sequences revealed
that 9F94 was more genetically related to MBB (genotype
IB) than to SLF-88 (see Figs. 1B and C). The apparent
discrepancy among the results found with VP1 and those
with VP2 and VP3 could be explained if a recombination
event took place between putative parental strains compa-
rable to MBB and SLF-88 (both isolated in the north of
Africa).
Phylogenetic profile and RIP analysis
To gain insight into a possible recombination event, a
phylogenetic profile analysis was carried out for all P1 HAV
sequences included in this study. The phylogenetic profile
derived from this data set is shown in Fig. 2. As can be seen
in the figure, profile analysis of the putative parental-like
(MBB, SFL88) and recombinant (9F94) strains show a
clearly visible point of recombination on position 1461 of
the analyzed sequences, corresponding to position 51 of the
VP1 protein (see Fig. 2A). However, when the parental
sequences SLF88, MBB, and the recombinant, 9F94, were
omitted and the same studies were done with all the other
sequences included in this work, no such obvious recombi-
nation junction was detected (see Fig. 2B). To confirm these
results, we performed the same analysis, but this time used
the recombination identification program (RIP) (Fig. 3). As
can be seen in the figure, the data obtained from the RIP
suggested that the 9F94 strain is the evolutionary product of
a recombination event between the putative parent strain
SLF88 and MBB.
Breakpoint analysis
To further characterize the putative recombinant site, we
have employed the LARD method (Holmes et al., 1999).
Simulations of sequence evolution under the null hypothesis
(i.e., no recombination) gave strong statistical support for
the alternative hypothesis of recombination (P  0.005).
The visual examination of the distribution of the likelihood
ratio expected by chance under the null hypothesis indicates
Table 1
Origins of HAV strains
Strain Genotypea Location Year Accession No.
HM-175 IA Australia 1976 M14707
FH2Japan IA Japan 2000 AB020568
HAF-203 IB Brazil 2001 AF268396
MBB IB North Africa 1978 M20273
CR326 IA Costa-Rica 1976 M10033
SLF-88 VII Sierra Leone 1988 AY032861
PA21 IIIA Panama 1980 M34084
GA76 IIIA USA 1976 M66695
AGM-27 V Kenya 1985 D00926
CY-145 IV Philippines 1988 M59286
P27 IIIA France 1999 AJ519486
9F94 II Morocco 1994 AJ519487
a According to Robertson et al. classification (Robertson et al., 1992).
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that the likelihood ratio was obtained with the real data set
(LR  70 give strong evidence for recombination at posi-
tion 1461) (see Fig. 4).
Profiles of synonymous and nonsynonymous substitution
in VP1, VP2, and VP3 among parental and recombinant
HAV
To gain insight into how recombination may affect the
mode of evolution of HAV, the variation in the rates of syn-
onymous (i.e., no amino acid coding change) and nonsynony-
mous (i.e., changes the amino acid coding assignment) substi-
tutions among parental and the putative mosaic HAV strains
were calculated for the VP1, VP2, and VP3 proteins (Fig. 5).
Synonymous distances are clearly significantly higher than
nonsynonymous ones for almost all pairwise comparisons (see
Fig. 5). As a consequence, the ratio of nonsynonymous-to-
synonymous amino acid substitutions (ka/ks) is very low along
all proteins studied. This has usually been associated with
purifying selection model acting at the level of amino acid
conservation. There is no evidence for adaptive selection in
any of the protein domains.
Interestingly, the rates of synonymous substitutions in
MBB-9F94 comparisons for VP2 and VP3 proteins are
significantly lower in both cases, while significantly higher
rates are obtained when the VP1 analysis is performed
(compare Fig. 5A and Figs. 5B and C). This likely is further
evidence of a different evolutionary history for the VP1
protein. Nevertheless, these studies also show that even
though recombination took place in the VP1 protein, it has
not produced a drastic change in the mode of evolution of
VP1 protein, since the nonsynonymous substitution rate was
maintained at a very low rate, as in the cases of VP2 and
VP3 (see Fig. 5). Thus, at least on this basis, the encoded
VP1 protein does not appear to have been perturbed by the
recombination event.
Discussion
HAV strains present in human populations have been
demonstrated to have substantial sequence heterogeneity
(Costa-Mattioli et al., 2001a,b, 2002; Jansen et al., 1990;
Robertson et al., 1991, 1992). On the basis of the nucleic
Fig. 1. Phylogenetic tree analysis of HAV using full-length sequences. Strains in the tree are shown by their names and their types are indicated in parentheses
(see Table 2 for geographical location, year of isolation, and accession numbers). Numbers at each node show bootstrap percentages obtained after 1000
replicates. VP1 protein phylogeny (C), VP2 protein phylogeny (A), VP3 protein phylogeny (B), and P1 [VP2 VP3 VP1] phylogeny (D) are shown. Strain
9F94 is indicated by an arrow and the two putative parental strains are underlined.
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acid heterogeneity, identified by sequencing discrete, par-
tial, selected regions of the genome (similar to VP1 amino-
terminal region and/or the putative VP1/2A region), HAV
isolates have been differentiated into seven genotypes (Rob-
ertson et al., 1991).
In the present study, analysis of complete sequences for
the VP1, VP2, and VP3 genes of recently isolated cases of
HAV provided the opportunity to test whether recombina-
tion may play a role in HAV genetic diversity. Recently, an
HAV subgenomic replicon was rescued by genetic recom-
bination HAV genomes carrying lethal mutations in domain
P3 (Gauss-Muller and Kusov, 2002). This HAV replicon
does not contain structural proteins (P1) which were re-
placed by the luciferase gene. Although this work strongly
indicates that HAV recombination took place, the replicon
system is not sufficient for detecting a recombination event
occurring in the capsid region.
Our results provide strong evidence that not only does
recombination occur between two genotypes of HAV (see
Figs. 2, 3, and 4), but also that it occurs in natural popula-
tions, since culture passage was not done in any of our
experiments. The apparent inadequacy of the short sequence
fragments providing a complete picture of recombinant
HAV strains of genetic relationships demonstrates the value
of obtaining complete sequences for multiple HAV genes.
Recombination in vivo in members of the family Picor-
naviridae has been previously observed (Furione et al.,
1993; Lipskaya et al., 1991; Minor et al., 1986). Kew and
Nottay (1984) reported the isolation of a recombinant polio
virus which contained sequences derived from all three
serotypes of poliovirus vaccine strains as a result of two
crossovers. More recently, recombination among vaccine
and wild-type polioviruses has been reported as a natural
means of evolution of poliovirus (Guillot et al., 2000).
Recombination has also been reported in other members
of the family, such as enteroviruses (Santti et al., 1999).
Recombination in poliovirus or enterovirus (even between
enterovirus; Kew et al., 2002) was first reported to occur
outside the capsid region (Cuervo et al., 2001; Guillot et al.,
2000; Kew et al., 2002; Kew and Nottay, 1984; Liu et al.,
2000). Recently, polio (Liu et al., 2000; Martin et al., 2002)
and foot and mouth disease virus capsid recombinants (Tosh
et al., 2002) have been reported. These results are in agree-
ment with those found in this HAV work. In the present
study, we report a recombinant event among VP1 genes
between two different genotypes of HAV. Recombination
may serve two opposite purposes: exploration of a new
combination of genomic region from different origins or
rescuing of viable genomes from debilitated parental ge-
nomes (Domingo and Holland, 1997; Lai, 1992). The epi-
demiologic and clinical implication of HAV capsid region
crossing over in particular are unknown. However, capsid
recombinant may provide selective advantage to the virus;
for example, the recombinant may be more transmissible
than the preexisting lineages.
As methods of sequence analysis are increasingly able to
distinguish recombination from other evolutionary pro-
cesses, it is expected that recombination events will be
found more often and in additional RNA viruses. Due to the
increased prevalence and hyperendemicity of HAV in some
regions of the world, such as north of Africa (where both the
putative parental-like strains MBB and SLF-88 and the
recombinant, 9F94, have been isolated), or South America,
where recent studies suggest a changing epidemiologic pat-
tern (Tanaka, 2000; Tapia-Conyer et al., 1999), it will be
important to analyze additional isolates to investigate the
frequency and impact of recombination in HAV.
Four human HAV genotypes (I, II, III, and VII) have
Fig. 4. Distribution of the likelihood ratios expected by chance. The distribution of likelihood ratios for the null hypothesis (i.e., no recombination) is shown.
The y-axis shows the number of simulations. Likelihood ratios are shown at the bottom of the figure. Arrow shows the likelihood ratio obtained for the real
data set.
Fig. 2. Phylogenetic profiles of HAV sequences. The y-axis gives distance correlations and x-axis shows fixed windows of 50 bp width and the nucleotide
position along the capsid region. In (A) the profile of MBB, SLF-88, and 9F4 sequences is shown. The recombination site is indicated by an arrow. The
diagram at the bottom of the figure denotes location of the recombination in the VP1 protein. In (B) the profile of all other sequences included in this work
are shown.
Fig. 3. Analysis of recombination events using the recombination identification program (RIP). The x-axes represent the nucleotide position along the capsid
region.
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been proposed to date on a basis of pairwise comparison of
a short, selected, VP1/2A 168-long nucleic acid sequence of
HAV genome (Robertson et al., 1992). One main assump-
tion of this analysis is that the short sequence is represen-
tative of the genome. However, recombination invalidates
this assumption by generating mosaic genomes, where dif-
ferent regions have different phylogenetic histories. If we
follow the classification criteria cited above, strain 9F94
should be classified as type II (Costa-Mattioli et al., 2002).
However, the complete sequence of VP1 showed that strain
9F94 more closely resembled that of strain SLF-88 of ge-
notype VII, and analysis of VP2 and VP3 revealed the
relatedness of these regions to strain MBB of genotype IB.
Since only one other representative of type II has been
identified to date, and since that identification is based on
limited sequence analysis (Robertson et al., 1992), the pos-
sibility exists that type II strains may not be a distinct
human genotype, but rather an artifact of classification
based on insufficient sequence analysis.
The recognition of recombination is important not only
for unraveling the phylogenetic history of genes, but also for
molecular phylogenetic inference. By ignoring the presence
of recombination, phylogenetic analysis may be severely
compromised (Posada and Crandall, 2001; Schierup and
Hein, 2000). For that reason, HAV phylogeny needs to be
revised in light of recombination.
Although there is good evidence that human strains are
closely related antigenically (Lemon, 1997), the possible
implication of HAV capsid recombination events generating
antigenic escape mutants cannot be ruled out. However the
distribution of nonsynonymous substitutions shows ex-
tremely low rates when compared with synonymous ones
(see Fig. 5). This suggests that the pattern of divergence
observed in HAV capsid proteins is due to negative selec-
tion against substitutions at the amino acid level, which
appears to be the main force shaping the pattern of nonsyn-
onymous substitutions. In contrast, the antigenic immuno-
genic sites of multiple serotype viruses, such as the hemag-
glutinin gene of influenza virus (Ina and Gojobori, 1994),
the complete capsid region of serotype A and C of FMDV
(Haydon et al., 2001), and the VP3 region of HIV (Seibert
et al., 1995), were subjected to positive selection by immune
pressure. Whether new HAV variants may appear, as a
result of recombination events for instance, it remains to be
established if their fitness permits them to be selected in
HAV population. However, the mode of HAV evolution
appears, at least in part, to explain why there is only one
serological group of HAV described so far.
Materials and methods
Virus strains
9F94 was recovered from a virus collection of the “Unite´
de Virologie” at the Centre Hoˆspitalier Universitaire,
Nantes. This strain comes from a 6-year-old French girl who
was hospitalized at the Centre Hospitalier Universitaire in
1994, after a 3-month holiday in Morocco.
RNA extraction
HAV RNA was extracted from 140 l serum samples
with the QIAamp Viral RNA Kit (QIAGEN) and from 400
l stool suspension (0.3 g stool diluted in 2 ml water) using
the RNeasy mini kit (QIAGEN) according to instructions
Fig. 5. Profiles of synonymous and nonsynonymous distances of putative
parentals vs recombinant. The profiles obtained for VP1, VP2, VP3, and
the capsid (VP2  VP3  VP1) proteins are shown in (A), (B), and (C),
respectively. Numbers at the left side of the figure denote distance. Num-
bers at the bottom of the figure show codon position in the mid point of the
window. For synonymous substitutions, comparison MBB-9F94 is shown
with a thin continuous line and comparison SLF88-9F94 is shown with a
thin dotted line. For nonsynonymous substitutions, MBB-9F94 is shown
with a thick continuous line, and SLF88-9F94 is shown with a thick dotted
line.
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provided by the manufacturers. The RNA extracted was
eluted from the columns with 50 l RNase-free water.
Reverse transcription
A RNA/primer mixture was prepared in a sterile 0.2-ml
tube as follows: 1 l of 10 mM stock solution of dNTPs
(Roche), 1 l of oligo(dT)12-18 (0.5 g/l) (Invitrogen), 5
l of RNA, and 5 l of sterile water. The RNA/primer
mixture was thawed on ice, incubated 5 min at 65°C, and
chilled on ice. From a master mix, 1 l Rnasin (20-40
units/ml) (Promega), 2 l of 0.1 M dithiothreitol (Invitro-
gen), 1.5 g of T4 gene 32 (Roche), 1 l (200 units)
Superscript II reverse transcriptase (GIBCO), and 4 l of
5 1st Strand Synthesis buffer (Invitrogen) was added to
the RNA/primer mixture. The reaction was incubated for 1 h
at 42°C and the reverse transcriptase was inactivated by
heating at 70°C for 15 min. One microliter of RNase H (1-4
units/l) (Invitrogen) was added and the reaction was incu-
bated for 20 min at 37°C. The cDNA was purified with the
QIAquick PCR purification kit (QIAGEN) used according
to the manufacturer’s recommendations. The cDNA was
eluted in 30 l of 10 mM Tris–Cl (pH 8.5) and kept on ice
until added to the long PCR reaction mix.
Long PCR
The PCR reactions were performed in thin-walled PCR
tubes in a total volume of 25 l containing with a final
concentration of 400 M of each dNTPs, 400 M of each
positive (757) and negative (3749) primers (see Table
1), 2.5 l 10 Advantage 2 PCR buffer (40 mM Tricine–
KOH, pH 8.7 at 25°C, 15 mM KOac, 3.5 mM Mg(Oac)2,
3.75 g/ml BSA, 0.005% of Tween, and 0.005% Nonidet
P-40) (Clontech), 2 l purified template cDNA, 0.5 l
Advantage Polymerase Mix [Titanium TaqDNA polymer-
ase, a small amount of proofreading polymerase, TaqStart
Antibody (1.1 g/l) in the following storage buffer: 1%
glycerol, 0.3 mM Tris–HCl, pH 8, 1.5 mM KCl, 1 M
EDTA]. PCR reactions were performed in a 9600 Thermal
cycler (Applied Biosystems) with the following cycle con-
ditions: hot start at 94°C for 2 min, denaturation for 30s,
annealing at 52 for 45 s, extension at 68°C for 3 min (15
cycles), 68°C for 3 min 30 s (10 cycles), 68°C for 4 min (10
cycles). A final extension step was performed for 10 min at
68°C.
Purification of amplicons
The PCR reaction was electrophoresed on a 1% agarose
gel. DNA bands were visualized with a UV transillumina-
tor. The DNA was directly purified using the ExoSAP-IT
enzymatic kit (Amersham).
Sequencing
The primers used to amplify and sequence the long PCR
fragment are described in Table 2. The sequence reaction
was carried out using the Big Dye DNA sequencing kit
(Perkin–Elmer) on a 373 DNA sequencer apparatus (Per-
kin–Elmer).
Sequence analysis
The sequences compared came from a single DNA copy
that spans the entire capsid coding region and in all cases
the long DNA was used to determine the sequences that
were entered in the recombination tests. The sequences were
aligned using the CLUSTAL W program (Thompson et al.,
1994). Using the software MEGA (Kumar et al., 1994),
phylogenetic trees were generated by the neighbor-joining
method applied to distance matrix obtained under the
Kimura two-parameter model (Felsenstein, 1993). As a
measure of the robustness of each node, we utilized the
bootstrap method (1000 pseudo-replicates).
Substitution rate analysis
The substitution rate along the VP2, VP3, and VP1 genes
were measured using a sliding window according to the
procedure used by Alvarez-Valin et al. (2000). Pairwise
nucleotide distances (synonymous and nonsynonymous)
within each window were estimated by the method of Com-
eron (1995) as implemented in the computer program k-
estimator (Ina and Gojobori, 1994). For those windows
where the method was inapplicable, the Jukes–Cantor
(Jukes and Cantor, 1969) method was used for correction
Table 2
Primers used to amplify HAV sequences
Primer Sequence Positiona
757 TTTCCAGACTGTTGGGAGTGG 758–778
1194 GGTTCCTGGTGACCAC 1187–1201
1249 AACAAACCATGAGGATAAACAGTC 1249–1226
1470 ATGATGAGAAATGAATTTAG 1470–1489
1584 CAGATTTCCAATCTTCCTGATC 1584–1563
1794 TGTTTTTGGAGAGGAGA 1794–1810
2011 TAAGGAGTGTCAGAAATCCAGGGA 2011–1988
HAV1 GTTTTGCTCCTTTTATCATGCTATG 2167–2192
HAV2 AGTCACACCTCTCCAGGAAAACTT 3308–3285
HAV3 TTCATTATTTCATGCTCCTC 3286–3627
HAV4 ACAAATAACAACTAAAAGACAA 2955–2934
HAV5 TTGTCTTTAGTTGTTATTTGTC 2934–2956
HAV6 AGGAAATGTCTCAGGTACTTTCTTT-
GCTAAAACTG
2414–2380
HAV7 CTGGAGTGAACCAGGCCATGCCATC 2691–2667
HAVX8 AGAGTCATATAGATTGCAGG 3106–3125
HAVX9 GAGCAGTGGATGGTTTGGG 2845–2863
HAVX10 TTGTTCTTTAATTTCCTG 3674–3657
3749 AACAGTCACAGAATGATGAAATC 3770–3778
a Position relative to the genome of HAV strain HM-175 (M14707).
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for multiple hits. The window had a size of 30 codons and
a movement of 15.
Detection of recombination by sequence comparison
To detect any possible events of recombination, the
“phylogenetic-profile” method that was recently described
(Weiller, 1998) was utilized. Briefly, the latter method con-
stitutes a novel way of graphically displaying the coherence
of the sequence relationships over the entire length of a set
of aligned homologous sequences and have demonstrated
sensitivity and accuracy for identifying recombinant se-
quences and their recombination junctions as well as detect-
ing hot spots of recombinational activity. Alternatively, RIP
(Siepel et al., 1995) was used to detect possible recombinant
sequences. A sliding window of 200-nucleotide base-pairs
in length was created and moved over the aligned query.
The threshold for statistical significance was 90%.
Breakpoint analysis
Once the recombinant strain and strains representing
possible parents were identified, the likely recombination
breakpoint was determined using LARD (Holmes et al.,
1999). Briefly, for every possible breakpoint, the sequence
alignment was divided into two independent regions for
which the branch lengths of a tree of the putative recombi-
nant and its two parent sequences were optimized. The two
results (likelihoods) obtained by using the separate regions
were then combined to give a likelihood score for that
breakpoint position and the breakpoint position that yielded
the highest likelihood was identified. This “recombination
model” likelihood then was compared, by using a likelihood
ratio test, to the likelihood obtained from the same data
under a model that permitted no recombination. To assess
whether the recombination model gave a significantly better
fit to the data than the null hypothesis of no recombination,
the likelihood ratio obtained by using the real data were
evaluated for significance against a null distribution of like-
lihood ratios produced by using Monte Carlo simulation of
sequences generated without recombination. Sequences
were simulated 200 times by using the maximum likelihood
model parameters and sequence lengths from the real data
using Seq-Gen (Rambaut and Grassly, 1997). The simulated
sequences then were subjected to the same breakpoint anal-
yses as the real data to produce the distribution of likelihood
ratios expected if no recombination had occurred among
them.
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